About Us
Science
Pipeline
Investors
Contact
Careers

Address:

1035 Cambridge St, 18a, Cambridge, Massachusetts 02141, US

Phone+1 (617) 798-6700
LinkedInLinkedIn
Terms of UsePrivacy Policy
© 2025 Ernexa Therapeutics Inc.

Get in touch with us!

Media

Explore our news section for company press releases, media coverage, upcoming events, and scientific presentations. Here you'll find the latest milestones, insights, and announcements as we advance our pipeline and expand our impact in cell therapies for cancer and autoimmune disease.

Any Year
CLINICALLEADER
Smart Trial Design In Cell Therapy: Fast-Tracking Without CompromisingRead more
Apr 10, 2025
CELLANDGENE
Smart Trial Design In Cell Therapy: Fast-Tracking Without CompromisingRead more
Apr 10, 2025
DRUG TARGET REVIEW
Episode 24 – Genetic engineering for allogeneic immunotherapyRead more
Oct 24, 2023
PMLIVE
The impact of cell therapies on cancer treatmentsRead more
Oct 13, 2023
EXEC EDGE
Eterna Therapeutics Teams with Lineage Cell on Transplant TherapiesRead more
Sep 6, 2023
CGTLIVE
mRNA-engineered iPSC-derived Cell Therapies Hold Potential for Tackling Solid TumorsRead more
Aug 14, 2023
DRUG TARGET REVIEW
The promise of iPSC-based multi-cell therapeuticsRead more
Jul 5, 2023
LONGEVITY TECHNOLOGY
Tapping the Potential of mRNA in Cellular Reprogramming and BeyondRead more
Jun 1, 2023
EXEC EDGE
Eterna Therapeutics Appoints Megan Yung as CSO, General CounselRead more
May 24, 2023
CGTLIVE
Kyle Garland, PhD on the Potential of mRNA-engineered iPSC-derived Cell Therapies for Solid TumorsRead more
May 18, 2023
2 of 2